Published in J Chromatogr B Analyt Technol Biomed Life Sci on June 13, 2009
Development of a new pre- and post-processing tool (SADAPT-TRAN) for nonlinear mixed-effects modeling in S-ADAPT. AAPS J (2011) 1.71
Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice. J Bone Miner Res (2010) 1.41
Severe hepatotoxicity after sevoflurane anesthesia in a child with mild renal dysfunction. Paediatr Anaesth (2005) 1.39
Toxicological characteristics of endocrine-disrupting chemicals: developmental toxicity, carcinogenicity, and mutagenicity. J Toxicol Environ Health B Crit Rev (2003) 1.10
Tumor pH-responsive flower-like micelles of poly(L-lactic acid)-b-poly(ethylene glycol)-b-poly(L-histidine). J Control Release (2007) 1.08
A virus-mimetic nanogel vehicle. Angew Chem Int Ed Engl (2008) 1.05
Improved antitumor activity and tumor targeting of NH(2)-terminal-specific PEGylated tumor necrosis factor-related apoptosis-inducing ligand. Mol Cancer Ther (2010) 1.02
Dose-linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats. Biopharm Drug Dispos (2007) 1.02
High frequency piezoelectric MEMS ultrasound transducers. IEEE Trans Ultrason Ferroelectr Freq Control (2007) 1.01
A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice. J Control Release (2008) 1.01
Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry. J Control Release (2003) 1.00
Effect of particle size on the dissolution behaviors of poorly water-soluble drugs. Arch Pharm Res (2012) 0.99
Transdermal delivery of diclofenac using microemulsions. Arch Pharm Res (2004) 0.98
Sensitive HPLC method for quantitation of paclitaxel (Genexol in biological samples with application to preclinical pharmacokinetics and biodistribution. J Pharm Biomed Anal (2005) 0.98
Biopersistence of silver nanoparticles in tissues from Sprague-Dawley rats. Part Fibre Toxicol (2013) 0.97
Synthesis, characterization, and pharmacokinetic studies of PEGylated glucagon-like peptide-1. Bioconjug Chem (2005) 0.97
Recovery from silver-nanoparticle-exposure-induced lung inflammation and lung function changes in Sprague Dawley rats. Nanotoxicology (2012) 0.96
Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int J Pharm (2010) 0.95
The therapeutic effect of human adult stem cells derived from adipose tissue in endotoxemic rat model. Int J Med Sci (2012) 0.94
Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types. Biomaterials (2011) 0.93
Challenges in wearable personal health monitoring systems. Conf Proc IEEE Eng Med Biol Soc (2014) 0.93
PEGylated TNF-related apoptosis-inducing ligand (TRAIL) analogues: pharmacokinetics and antitumor effects. Bioconjug Chem (2011) 0.92
Preparation, characterization, and application of biotinylated and biotin-PEGylated glucagon-like peptide-1 analogues for enhanced oral delivery. Bioconjug Chem (2007) 0.92
Improved intestinal delivery of salmon calcitonin by Lys18-amine specific PEGylation: stability, permeability, pharmacokinetic behavior and in vivo hypocalcemic efficacy. J Control Release (2006) 0.92
A smart polysaccharide/drug conjugate for photodynamic therapy. Angew Chem Int Ed Engl (2011) 0.92
The effect of lidocaine on the globule size distribution of propofol emulsions. Anesth Analg (2003) 0.91
Optimization of ibuprofen gel formulations using experimental design technique for enhanced transdermal penetration. Int J Pharm (2008) 0.90
A randomized placebo-controlled, dose-finding study of oral LB80380 in HBeAg-positive patients with chronic hepatitis B. Antivir Ther (2006) 0.90
PEGylated TNF-related apoptosis-inducing ligand (TRAIL) for effective tumor combination therapy. Biomaterials (2011) 0.88
Use of an anti-vascular endothelial growth factor antibody in a pharmacokinetic strategy to increase the efficacy of intraperitoneal chemotherapy. J Pharmacol Exp Ther (2009) 0.88
Doxorubicin-loaded highly porous large PLGA microparticles as a sustained- release inhalation system for the treatment of metastatic lung cancer. Biomaterials (2012) 0.88
Hyaluronic acid-tumor necrosis factor-related apoptosis-inducing ligand conjugate for targeted treatment of liver fibrosis. Acta Biomater (2014) 0.87
PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity. J Control Release (2010) 0.87
Mono-PEGylated dimeric exendin-4 as high receptor binding and long-acting conjugates for type 2 anti-diabetes therapeutics. Bioconjug Chem (2011) 0.87
Determination of zearalenone by liquid chromatography/tandem mass spectrometry and application to a pharmacokinetic study. Biomed Chromatogr (2009) 0.87
Interspecies comparison of the oral absorption of itraconazole in laboratory animals. Arch Pharm Res (2002) 0.87
Physiologically based pharmacokinetics of bisphenol A. J Toxicol Environ Health A (2004) 0.87
Biochemical, pharmaceutical and therapeutic properties of long-acting lithocholic acid derivatized exendin-4 analogs. J Control Release (2009) 0.87
Di(2-ethylhexyl) phthalate induces apoptosis through peroxisome proliferators-activated receptor-gamma and ERK 1/2 activation in testis of Sprague-Dawley rats. J Toxicol Environ Health A (2007) 0.87
Investigation of the release behavior of DEHP from infusion sets by paclitaxel-loaded polymeric micelles. Int J Pharm (2005) 0.86
Antithrombotic and antiplatelet activities of fenofibrate, a lipid-lowering drug. Atherosclerosis (2009) 0.86
Sensitive high performance liquid chromatographic assay for assessment of doxorubicin pharmacokinetics in mouse plasma and tissues. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 0.86
Investigation of formulation factors affecting in vitro and in vivo characteristics of a galantamine transdermal system. Int J Pharm (2012) 0.86
Preparation of highly porous gastroretentive metformin tablets using a sublimation method. Eur J Pharm Biopharm (2012) 0.86
Pharmacokinetics of baicalein, baicalin and wogonin after oral administration of a standardized extract of Scutellaria baicalensis, PF-2405 in rats. Arch Pharm Res (2007) 0.86
Corticotomy-assisted decompensation for augmentation of the mandibular anterior ridge. Am J Orthod Dentofacial Orthop (2011) 0.85
Site-specific PEGylated Exendin-4 modified with a high molecular weight trimeric PEG reduces steric hindrance and increases type 2 antidiabetic therapeutic effects. Bioconjug Chem (2012) 0.85
Highly porous large poly(lactic-co-glycolic acid) microspheres adsorbed with palmityl-acylated exendin-4 as a long-acting inhalation system for treating diabetes. Biomaterials (2010) 0.84
Role of metabolism by intestinal bacteria in arbutin-induced toxicity in vitro. Arch Pharm Res (2011) 0.84
Liquid chromatography-electrospray ionization tandem mass spectrometric determination of lornoxicam in human plasma. Arch Pharm Res (2007) 0.84
PEG-transferrin conjugated TRAIL (TNF-related apoptosis-inducing ligand) for therapeutic tumor targeting. J Control Release (2012) 0.84
Self-assembled glycol chitosan nanogels containing palmityl-acylated exendin-4 peptide as a long-acting anti-diabetic inhalation system. J Control Release (2012) 0.84
Validation study of OECD rodent uterotrophic assay for the assessment of estrogenic activity in Sprague-Dawley immature female rats. J Toxicol Environ Health A (2005) 0.84
Transport of a new erectogenic udenafil in Caco-2 cells. Arch Pharm Res (2007) 0.84
In Vitro/in vivo relationship of gabapentin from a sustained-release tablet formulation: a pharmacokinetic study in the beagle dog. Arch Pharm Res (2008) 0.83
Antiplatelet and antithrombotic activities of Korean Red Ginseng. Arch Pharm Res (2006) 0.83
Carbohydrate-specifically polyethylene glycol-modified ricin A-chain with improved therapeutic potential. Int J Biochem Cell Biol (2005) 0.83
Clitocybin A, a novel isoindolinone, from the mushroom Clitocybe aurantiaca, inhibits cell proliferation through G1 phase arrest by regulating the PI3K/Akt cascade in vascular smooth muscle cells. J Pharmacol Sci (2012) 0.83
Maternal-fetal disposition of bisphenol a in pregnant Sprague-Dawley rats. J Toxicol Environ Health A (2002) 0.83
Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity. J Cardiovasc Pharmacol (2008) 0.82
Pharmacokinetic scaling of bisphenol A by species-invariant time methods. Xenobiotica (2002) 0.82
Disposition, oral bioavailability, and tissue distribution of zearalenone in rats at various dose levels. J Toxicol Environ Health A (2009) 0.81
Preparation and evaluation of palmitic acid-conjugated exendin-4 with delayed absorption and prolonged circulation for longer hypoglycemia. Int J Pharm (2011) 0.81
Development of a liquid chromatography/electrospray tandem mass spectrometry assay for the quantification of apicidin, a novel histone deacetylase inhibitor, in rat serum: application to a pharmacokinetic study. Rapid Commun Mass Spectrom (2005) 0.81
Effect of flavors on the viscosity and gelling point of aqueous poloxamer solution. Arch Pharm Res (2006) 0.81
Investigation of polymeric excipients for dutasteride solid dispersion and its physicochemical characterization. Arch Pharm Res (2013) 0.81
Development of vorinostat-loaded solid lipid nanoparticles to enhance pharmacokinetics and efficacy against multidrug-resistant cancer cells. Pharm Res (2014) 0.81
Size-dependent clearance of gold nanoparticles from lungs of Sprague-Dawley rats after short-term inhalation exposure. Arch Toxicol (2014) 0.80
The reversal of drug-resistance in tumors using a drug-carrying nanoparticular system. Int J Mol Sci (2009) 0.80
Assessment of bisphenol A exposure in Korean pregnant women by physiologically based pharmacokinetic modeling. J Toxicol Environ Health A (2010) 0.80
Development of propofol-loaded microemulsion systems for parenteral delivery. Arch Pharm Res (2005) 0.80
Application of instrumental evaluation of color for the pre-formulation and formulation of rabeprazole. Int J Pharm (2007) 0.80
Low molecular weight (1 kDa) polyethylene glycol conjugation markedly enhances the hypoglycemic effects of intranasally administered exendin-4 in type 2 diabetic db/db mice. Biol Pharm Bull (2012) 0.80
Determination and pharmacokinetics of [6]-gingerol in mouse plasma by liquid chromatography-tandem mass spectrometry. Biomed Chromatogr (2011) 0.80
No androgenic/anti-androgenic effects of bisphenol-A in Hershberger assay using immature castrated rats. Toxicol Lett (2002) 0.80
Toxicokinetics of phthalic acid: the common final metabolite of phthalic acid esters in rats. J Toxicol Environ Health A (2007) 0.80
Development of LC/MS/MS assay for the determination of 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazine-1-sulfonyl]-2-propoxyphenyl}-7-propyl-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one (SK3530) in human plasma: application to a clinical pharmacokinetic study. J Pharm Biomed Anal (2007) 0.80
Low cost electroencephalographic acquisition amplifier to serve as teaching and research tool. Conf Proc IEEE Eng Med Biol Soc (2011) 0.80
Liquid chromatography-tandem mass spectrometry determination of baclofen in various biological samples and application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci (2013) 0.80
Physiologically based pharmacokinetics of zearalenone. J Toxicol Environ Health A (2009) 0.79
Chemopreventive mechanisms of methionine on inhibition of benzo(a)pyrene-DNA adducts formation in human hepatocellular carcinoma HepG2 cells. Toxicol Lett (2011) 0.79
Pharmacokinetic and pharmacodynamic evaluation of site-specific PEGylated glucagon-like peptide-1 analogs as flexible postprandial-glucose controllers. J Pharm Sci (2009) 0.79
Synthesis and evaluation of human serum albumin-modified exendin-4 conjugate via heterobifunctional polyethylene glycol linkage with protracted hypoglycemic efficacy. Bioconjug Chem (2010) 0.79
Chromatographic separation and mass spectrometric identification of positional isomers of polyethylene glycol-modified growth hormone-releasing factor (1-29). J Chromatogr A (2004) 0.79
DJ-1/park7 protects against neointimal formation via the inhibition of vascular smooth muscle cell growth. Cardiovasc Res (2012) 0.79
In vitro / in vivo evaluation of NCDS-micro-fabricated biodegradable implant. Arch Pharm Res (2010) 0.79
Determination of clopidogrel in human plasma by liquid chromatography/tandem mass spectrometry: application to a clinical pharmacokinetic study. Biomed Chromatogr (2007) 0.79
Interspecies scaling of oleanolic acid in mice, rats, rabbits and dogs and prediction of human pharmacokinetics. Arch Pharm Res (2009) 0.79
Translational possibility of [(18) F]Mefway to image serotonin 1A receptors in humans: Comparison with [(18) F]FCWAY in rodents. Synapse (2014) 0.79
Simultaneous determination of fimasartan, a novel antihypertensive agent, and its active metabolite in rat plasma by liquid chromatography-tandem mass spectrometry. Biomed Chromatogr (2011) 0.79